"Mycobacterium bovis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.
| Descriptor ID |
D009163
|
| MeSH Number(s) |
B03.510.024.049.525.500.402 B03.510.460.400.410.552.552.402
|
| Concept/Terms |
BCG- BCG
- Calmette-Guerin Bacillus
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium bovis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium bovis".
This graph shows the total number of publications written about "Mycobacterium bovis" by people in this website by year, and whether "Mycobacterium bovis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 15 | 6 | 21 |
| 2018 | 13 | 3 | 16 |
| 2019 | 0 | 4 | 4 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mycobacterium bovis" by people in Profiles.
-
The safety of BCG revaccination: A systematic review. Vaccine. 2021 05 12; 39(20):2736-2745.
-
Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence. Iran J Allergy Asthma Immunol. 2021 Feb 11; 20(1):106-113.
-
An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination. Prep Biochem Biotechnol. 2021; 51(7):650-658.
-
Bacillus Calmette-Guérin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally. Vaccine. 2020 11 10; 38(48):7629-7637.
-
[Disseminated infection caused by the bacillus Calmette-Guérin vaccine and SARS-CoV-2 coinfection in a patient with IL-12 receptor ß1 subunit deficiency]. Rev Alerg Mex. 2020 Oct-Dec; 67(4):401-407.
-
Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. J Proteome Res. 2020 11 06; 19(11):4649-4654.
-
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis. Vaccine. 2020 09 22; 38(41):6352-6356.
-
The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic. Vaccine. 2020 09 22; 38(41):6374-6380.
-
A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization. Cytokine Growth Factor Rev. 2020 08; 54:32-42.
-
Post-mortem surveillance of bovine tuberculosis in Ireland: herd-level variation in the probability of herds disclosed with lesions at routine slaughter to have skin test reactors at follow-up test. Vet Res Commun. 2020 Nov; 44(3-4):131-136.